Your browser doesn't support javascript.
loading
Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.
Dash, Rasmita; Yadav, Madhulika; Biswal, Jyotirmaya; Chandra, Anshuman; Goel, Vijay Kumar; Sharma, Tripti; Prusty, Shakti Ketan; Mohapatra, Sujata.
Afiliación
  • Dash R; Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
  • Yadav M; Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
  • Biswal J; Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
  • Chandra A; School of Physical Science, Jawaharlal Nehru University, New Delhi, Delhi 110067, India.
  • Goel VK; School of Physical Science, Jawaharlal Nehru University, New Delhi, Delhi 110067, India.
  • Sharma T; Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
  • Prusty SK; Department of Pharmacology, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India.
  • Mohapatra S; Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar 751003, Odisha, India. Electronic address: sujatamohapatra@soa.ac.in.
Int J Pharm ; 640: 123009, 2023 Jun 10.
Article en En | MEDLINE | ID: mdl-37142139

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Curcumina / Quitosano / Aterosclerosis / Nanopartículas Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Curcumina / Quitosano / Aterosclerosis / Nanopartículas Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Int J Pharm Año: 2023 Tipo del documento: Article País de afiliación: India